{"id":10700,"date":"2025-05-28T10:16:34","date_gmt":"2025-05-28T10:16:34","guid":{"rendered":"https:\/\/navarrahealthcluster.com\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/"},"modified":"2025-05-28T10:38:54","modified_gmt":"2025-05-28T10:38:54","slug":"formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa","status":"publish","type":"post","link":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/","title":{"rendered":"Key training in CMC for small molecules and biologics in Europe"},"content":{"rendered":"\n<p>The third session of <a href=\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\">the regulatory training series<\/a> took place on 27 May 2025, focusing on &#8220;Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe&#8221;. Organised by Navarra Health Cluster and <a href=\"https:\/\/navarrahealthcluster.com\/en\/partners\/asphalion\/\">Asphalion<\/a>, the event brought together 22 participants from 7 different organisations to explore the regulatory challenges in biopharmaceutical and healthcare innovation. <\/p>\n\n<p>During the session, key topics were covered, including the development and registration of medicinal products, emphasising the importance of safety, efficacy, and quality at every stage of the product lifecycle. Additionally, the EU regulatory frameworks for small molecules and biological products were presented, along with the ICH guidelines and the structure of the Common Technical Document (CTD). <\/p>\n\n<p>The topics covered included an introduction to the key regulatory aspects of Chemistry, Manufacturing and Controls (CMC) for small molecules and biologics in Europe. The session also addressed the structure and content of Modules 2.3 and 3 of the Common Technical Document (CTD), which are essential for the development and registration of medicinal products. <\/p>\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"810\" height=\"1080\" src=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-810x1080.jpg\" alt=\"third session of the regulatory training series\" class=\"wp-image-10690\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-810x1080.jpg 810w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-450x600.jpg 450w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-768x1024.jpg 768w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-1152x1536.jpg 1152w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-1536x2048.jpg 1536w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1817-scaled.jpg 1920w\" sizes=\"(max-width: 810px) 100vw, 810px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"810\" height=\"1080\" src=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-810x1080.jpg\" alt=\"third session of the regulatory training series\" class=\"wp-image-10687\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-810x1080.jpg 810w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-450x600.jpg 450w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-768x1024.jpg 768w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-1152x1536.jpg 1152w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-1536x2048.jpg 1536w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_1838-scaled.jpg 1920w\" sizes=\"(max-width: 810px) 100vw, 810px\" \/><\/figure>\n<\/div>\n<\/div>\n\n<p>The active participation and knowledge exchange among attendees reflect our community\u2019s commitment to excellence in regulation and the advancement of innovation in the healthcare sector. Participants had the opportunity to discuss and share experiences on best practices and strategies to meet regulatory requirements and ensure success in the development of new products. <\/p>\n\n<p>This third session of the regulatory series was a resounding success, providing valuable insights and fostering collaboration among industry professionals. We look forward with great anticipation to the upcoming sessions, which will continue to address essential topics in biopharmaceutical and healthcare regulation and innovation. <\/p>\n\n<p>Interested in healthcare regulation topics? Don\u2019t miss our upcoming sessions: <a href=\"https:\/\/navarrahealthcluster.com\/en\/events\/\">Agenda \u2022 Navarra Health Cluster<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>The third session of the regulatory training series took place on 27 May 2025, focusing on &#8220;Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe&#8221;. Organised by Navarra Health Cluster and Asphalion, the event brought together 22 participants from 7 different organisations to explore the regulatory challenges in biopharmaceutical [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":10695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-10700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster<\/title>\n<meta name=\"description\" content=\"The third session of the regulatory training series took place on 27 May 2025, focusing on &quot;Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster\" \/>\n<meta property=\"og:description\" content=\"The third session of the regulatory training series took place on 27 May 2025, focusing on &quot;Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\" \/>\n<meta property=\"og:site_name\" content=\"Navarra Health Cluster\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-28T10:16:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-28T10:38:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jessica swiderski\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica swiderski\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\"},\"author\":{\"name\":\"Jessica swiderski\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05\"},\"headline\":\"Key training in CMC for small molecules and biologics in Europe\",\"datePublished\":\"2025-05-28T10:16:34+00:00\",\"dateModified\":\"2025-05-28T10:38:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\"},\"wordCount\":286,\"publisher\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\",\"url\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\",\"name\":\"Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster\",\"isPartOf\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg\",\"datePublished\":\"2025-05-28T10:16:34+00:00\",\"dateModified\":\"2025-05-28T10:38:54+00:00\",\"description\":\"The third session of the regulatory training series took place on 27 May 2025, focusing on \\\"Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage\",\"url\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg\",\"contentUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\/\/navarrahealthcluster.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualidad\",\"item\":\"https:\/\/navarrahealthcluster.com\/category\/actualidad\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Key training in CMC for small molecules and biologics in Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#website\",\"url\":\"https:\/\/navarrahealthcluster.com\/\",\"name\":\"Navarra Health Cluster\",\"description\":\"La mayor alianza en salud y biociencias de Navarra\",\"publisher\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/navarrahealthcluster.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\",\"name\":\"Navarra Health Cluster\",\"url\":\"https:\/\/navarrahealthcluster.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png\",\"contentUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png\",\"width\":393,\"height\":116,\"caption\":\"Navarra Health Cluster\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/navarrahealthcluster\/posts\/?feedView=all\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05\",\"name\":\"Jessica swiderski\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g\",\"caption\":\"Jessica swiderski\"},\"url\":\"https:\/\/navarrahealthcluster.com\/en\/author\/navarra-capital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster","description":"The third session of the regulatory training series took place on 27 May 2025, focusing on \"Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/","og_locale":"en_US","og_type":"article","og_title":"Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster","og_description":"The third session of the regulatory training series took place on 27 May 2025, focusing on \"Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe\".","og_url":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/","og_site_name":"Navarra Health Cluster","article_published_time":"2025-05-28T10:16:34+00:00","article_modified_time":"2025-05-28T10:38:54+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg","type":"image\/jpeg"}],"author":"Jessica swiderski","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jessica swiderski","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#article","isPartOf":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/"},"author":{"name":"Jessica swiderski","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05"},"headline":"Key training in CMC for small molecules and biologics in Europe","datePublished":"2025-05-28T10:16:34+00:00","dateModified":"2025-05-28T10:38:54+00:00","mainEntityOfPage":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/"},"wordCount":286,"publisher":{"@id":"https:\/\/navarrahealthcluster.com\/#organization"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/","url":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/","name":"Key training in CMC for small molecules and biologics in Europe &#8226; Navarra Health Cluster","isPartOf":{"@id":"https:\/\/navarrahealthcluster.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg","datePublished":"2025-05-28T10:16:34+00:00","dateModified":"2025-05-28T10:38:54+00:00","description":"The third session of the regulatory training series took place on 27 May 2025, focusing on \"Key Aspects of Chemistry, Manufacturing and Controls (CMC) for Small Molecules and Biologics in Europe\".","breadcrumb":{"@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#primaryimage","url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg","contentUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_E1833-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/navarrahealthcluster.com\/en\/formacion-sobre-los-aspectos-clave-de-quimica-fabricacion-y-controles-cmc-para-pequenas-moleculas-y-biologicos-en-europa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/navarrahealthcluster.com\/"},{"@type":"ListItem","position":2,"name":"Actualidad","item":"https:\/\/navarrahealthcluster.com\/category\/actualidad\/"},{"@type":"ListItem","position":3,"name":"Key training in CMC for small molecules and biologics in Europe"}]},{"@type":"WebSite","@id":"https:\/\/navarrahealthcluster.com\/#website","url":"https:\/\/navarrahealthcluster.com\/","name":"Navarra Health Cluster","description":"La mayor alianza en salud y biociencias de Navarra","publisher":{"@id":"https:\/\/navarrahealthcluster.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/navarrahealthcluster.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/navarrahealthcluster.com\/#organization","name":"Navarra Health Cluster","url":"https:\/\/navarrahealthcluster.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/","url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png","contentUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png","width":393,"height":116,"caption":"Navarra Health Cluster"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/navarrahealthcluster\/posts\/?feedView=all"]},{"@type":"Person","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05","name":"Jessica swiderski","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g","caption":"Jessica swiderski"},"url":"https:\/\/navarrahealthcluster.com\/en\/author\/navarra-capital\/"}]}},"_links":{"self":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/comments?post=10700"}],"version-history":[{"count":2,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10700\/revisions"}],"predecessor-version":[{"id":10702,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10700\/revisions\/10702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/media\/10695"}],"wp:attachment":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/media?parent=10700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/categories?post=10700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/tags?post=10700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}